tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 120 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
tecfidera 240 mg
medison pharma ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimetyl fumarate - tecfidera is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
translarna 1000 mg
medison pharma ltd - ataluren - granules for oral suspension - ataluren 1000 mg - ataluren - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.
translarna 125 mg
medison pharma ltd - ataluren - granules for oral suspension - ataluren 125 mg - ataluren - translarna is indicated for the treatment of duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older. the presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing